Disparities in Insulin Pump Use Among Spanish-Speaking Children With Type 1 Diabetes Compared to Their Non-Hispanic White Peers: Mixed Methods Study.
Spanish-speaking
children
diabetes
diabetes mellitus
disparities
glucose monitoring
insulin
insulin pump
type 1 diabetes
Journal
JMIR diabetes
ISSN: 2371-4379
Titre abrégé: JMIR Diabetes
Pays: Canada
ID NLM: 101719410
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
received:
20
01
2023
accepted:
15
05
2023
revised:
28
04
2023
medline:
9
6
2023
pubmed:
9
6
2023
entrez:
9
6
2023
Statut:
epublish
Résumé
Disparities in Insulin Pump Use Among Spanish-Speaking Children With Type 1 Diabetes Compared to Their Non-Hispanic White Peers: Mixed Methods Study. We aimed to investigate the use of insulin pumps and continuous glucose monitoring (CGM) devices among Spanish-language-preferring children in our clinic population and to identify specific barriers to technology use. First, we assessed rates and patterns of diabetes technology use (eg, insulin pumps and CGM devices) in a sample of 76 children (38 Spanish-language preferring and 38 non-Hispanic White). We compared rates of technology use, average length of time between diabetes diagnosis and initiation of insulin pump or CGM device, and rates of discontinuation of these devices between the Spanish-language-preferring and non-Hispanic White children. Second, to understand specific barriers to technology use, we compared responses to a questionnaire assessing decision-making about insulin pumps. Spanish-language-preferring patients had lower rates of insulin pump use, even after controlling for age, gender, age at diagnosis, and type of health insurance. Spanish-language-preferring participants were more likely to report concerns over learning to use an insulin pump and were more likely to discontinue using an insulin pump after starting one. These data confirm demographic disparities in insulin pump use among children with T1D and provide new insights about insulin pump discontinuation among Spanish-language-preferring children. Our findings suggest a need for improved patient education about insulin pump technology in general and improved support for Spanish-language-preferring families with T1D after initiation of pump therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Disparities in Insulin Pump Use Among Spanish-Speaking Children With Type 1 Diabetes Compared to Their Non-Hispanic White Peers: Mixed Methods Study.
OBJECTIVE
OBJECTIVE
We aimed to investigate the use of insulin pumps and continuous glucose monitoring (CGM) devices among Spanish-language-preferring children in our clinic population and to identify specific barriers to technology use.
METHODS
METHODS
First, we assessed rates and patterns of diabetes technology use (eg, insulin pumps and CGM devices) in a sample of 76 children (38 Spanish-language preferring and 38 non-Hispanic White). We compared rates of technology use, average length of time between diabetes diagnosis and initiation of insulin pump or CGM device, and rates of discontinuation of these devices between the Spanish-language-preferring and non-Hispanic White children. Second, to understand specific barriers to technology use, we compared responses to a questionnaire assessing decision-making about insulin pumps.
RESULTS
RESULTS
Spanish-language-preferring patients had lower rates of insulin pump use, even after controlling for age, gender, age at diagnosis, and type of health insurance. Spanish-language-preferring participants were more likely to report concerns over learning to use an insulin pump and were more likely to discontinue using an insulin pump after starting one.
CONCLUSIONS
CONCLUSIONS
These data confirm demographic disparities in insulin pump use among children with T1D and provide new insights about insulin pump discontinuation among Spanish-language-preferring children. Our findings suggest a need for improved patient education about insulin pump technology in general and improved support for Spanish-language-preferring families with T1D after initiation of pump therapy.
Identifiants
pubmed: 37294607
pii: v8i1e45890
doi: 10.2196/45890
pmc: PMC10334715
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e45890Informations de copyright
©Lindsey Loomba, Shaila Bonanno, Diana Arellano, Stephanie Crossen, Nicole Glaser. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 09.06.2023.
Références
Pediatrics. 2015 Mar;135(3):424-34
pubmed: 25687140
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1205-1215
pubmed: 35026013
J Pediatr. 2009 Aug;155(2):183-9.e1
pubmed: 19394043
J Diabetes Sci Technol. 2022 Jul;16(4):834-843
pubmed: 34225480
Diabetes Technol Ther. 2020 Oct;22(10):760-767
pubmed: 32163719
Ann Fam Med. 2013 Jan-Feb;11(1):43-52
pubmed: 23319505
Am J Public Health. 2015 Dec;105(12):e60-76
pubmed: 26469668
Endocrinol Metab Clin North Am. 2021 Sep;50(3):475-490
pubmed: 34399957
Diabetologia. 2016 Jan;59(1):87-91
pubmed: 26546085
Pediatr Diabetes. 2019 Jun;20(4):468-473
pubmed: 30938029
Pediatr Diabetes. 2021 Mar;22(2):241-248
pubmed: 33871154
BMC Med Ethics. 2017 Mar 1;18(1):19
pubmed: 28249596
Diabetes Technol Ther. 2017 Jun;19(6):363-369
pubmed: 28581817
J Diabetes Res. 2018 Jul 29;2018:5162162
pubmed: 30151393
Diabetes Technol Ther. 2023 Feb;25(2):131-139
pubmed: 36475821
Ann Intern Med. 2012 Sep 4;157(5):336-47
pubmed: 22777524
Diabetes Care. 2018 May;41(5):1017-1024
pubmed: 29496742
Diabetes Care. 2022 Jan 1;45(Suppl 1):S97-S112
pubmed: 34964871
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336